Guizhou Xinbang Pharmaceutical Co (SZSE:002390) 3-Year Revenue Growth Rate : -5.80% (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co 3-Year Revenue Growth Rate?

Guizhou Xinbang Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥0.70.

During the past 12 months, Guizhou Xinbang Pharmaceutical Co's average Revenue per Share Growth Rate was -11.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -5.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -5.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Guizhou Xinbang Pharmaceutical Co was 85.70% per year. The lowest was -7.00% per year. And the median was 6.55% per year.

Competitive Comparison of Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Guizhou Xinbang Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Guizhou Xinbang Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Xinbang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN

Website

http://www.xinbang.com

Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.

Executives

An Ji	Director
Gao Wen Lin	Executives
Lu Ya Fang	Executives
Xu Qi	Directors, executives
An Huai Lve	Director
Ma Cheng	Director
Zhang Jie Qing	Directors, executives
Kong Ling Zhong	Directors, executives
Liu Xiao Yang	Executives
Xiao Ya Yun	Executives
Yang Pei	Executives
Zhang Guan Fu	Director
Chen Chuan	Directors, executives
He Wen Jun	Supervisors
Lv Yu Tao	Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines